'It is scary to pause treatment': perspectives on HIV cure-related research and analytical treatment interruptions from women diagnosed during acute HIV in Durban, South Africa.

Journal: HIV research & clinical practice

Volume: 26

Issue: 1

Year of Publication: 2025

Affiliated Institutions:  Integration of TB in Education and Care for HIV/AIDS (ITEACH), Durban, South Africa. Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA. Center for Gender and Health Justice, University of California Global Health Institute, Los Angeles, CA, USA. Females Rising through Education, Support and Health (FRESH), Durban, South Africa. School of Applied Human Sciences, Department of Social Work, University of KwaZulu-Natal (UKZN), Durban, South Africa. Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, CA, USA. Department of Ecology and Evolutionary Biology, University of California Los Angeles (UCLA), CA, USA.

Abstract summary 

HIV remains a major challenge in KwaZulu-Natal, South Africa, particularly for young women who face disproportionate risks and barriers to prevention and treatment. Most HIV cure trials, however, occur in high-income countries.To examine the perspectives of young women diagnosed with acute HIV in a longitudinal study, focusing on their perceptions on ATI-inclusive HIV cure trials and the barriers and facilitators to participation.Between October 2022 and February 2024, we conducted closed-ended surveys and in-depth interviews with 20 women aged 19-33 living with HIV, who were willing but ineligible or unable to participate in an HIV cure trial.Many participants reported mental health challenges, including major depression (40%), moderate to severe anxiety (35%), and low self-esteem (35%). While women diagnosed during acute HIV supported pausing antiretroviral treatment (ART) during analytical treatment interruption (ATI) to advance HIV cure research, concerns about health risks and HIV-related stigma were significant barriers to enrollment. Trust in the research team and close monitoring were seen as positive factors, while fears around sharing of HIV/ATI status and transmission to sex partners complicated decision-making. Participants expressed a need for psychological counseling and access to community resources to manage ATI-related stressors.Understanding women's perspectives on HIV cure research, especially ATI trials, is vital. Building trust and addressing psychosocial challenges through a healing-centered approach can facilitate trial participation. Socio-behavioral research before and during HIV cure trials will be essential to inform participant-centered protocol design.

Authors & Co-authors:  Mthimkhulu Deli D Dong Krista L KL Ngcobo Mzwakhe Wiseman MW Mindry Deborah D Zulu Ayanda A Langa Ntombifuthi N Maphalala Luyanda L Pillay Vanessa V Mthembu Maud M Miall Annie A Tran Whitney W Dillen Ana A Wan Fang F Ahmed Ali A Stockman Jamila K JK Hussain Maryam M Ndung'u Thumbi T Dubé Karine K

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  18
Identifiers
Doi : 10.1080/25787489.2025.2455917
SSN : 2578-7470
Study Population
Women
Mesh Terms
Humans
Other Terms
HIV cure research;HIV prevention;HIV treatment;South Africa;Women living with HIV;socio-behavioral sciences
Study Design
Longitudinal Study
Study Approach
Country of Study
South Africa
Publication Country
England